Last reviewed · How we verify
The injectable TQD3606 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
The injectable TQD3606 (The injectable TQD3606) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| The injectable TQD3606 TARGET | The injectable TQD3606 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- The injectable TQD3606 CI watch — RSS
- The injectable TQD3606 CI watch — Atom
- The injectable TQD3606 CI watch — JSON
- The injectable TQD3606 alone — RSS
Cite this brief
Drug Landscape (2026). The injectable TQD3606 — Competitive Intelligence Brief. https://druglandscape.com/ci/the-injectable-tqd3606. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab